Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
Clinical trial NCT07398326 · RECRUITING
Trial details
- NCT number
- NCT07398326
- Sponsor
- Shanghai Changzheng Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-24
- Primary completion
- 2027-12-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.